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Heart failure is characterized by inability of the heart to
deliver oxygen to the tissues at a rate commensurate with
oxygen demand. With mild cardiac failure. the deficitoccurs
only during physicalactivity; when severe, it may exist even
at rest. The prevalence of heart failure increases exponen-
tially with age (I), with an eightfold increase among men
in the seventh as compared with the fifth decade in the
Framingham population (2). At all ages men have higher
rates of heart failure than do women, but this condition is
both overdiagnosed and underdiagnosed. The prognosis is
poor. with less than half the patients surviving 5 years after
the diagnosis of heart failure and fewer than 50% of patients
in New York Heart Association class IV surviving for 1
year (I).
Etiology
The most common causes of heart failure in an elderly
population arc ischemic heart disease and hypertension. An-
other common cause is valvular heart disease. especially
calcific aortic valve disease; cardiomyopathy. particularly
amyloid heart disease, is a less frequent cause.
Specific[actors precipitating heartfailure are more com-
mon and important in the elderly patient (3), mandating
attention to their detectionand correction. Bradyarrhythmias
or tachyarrhythmias, particularly atrial fibrillation with loss
of the atrial contribution to ventricular filling and complete
atrioventricular (AV) block, are often implicated. Heart fail-
ure may be precipitated by myocardial infarction (4). acute
valvular regurgitation, anemia, infection and fever. hyper-
or hypothyroidism, renal insufficiency, dietary sodium ex-
cess. alcohol abuse, fluid overload, the administration of
drugs that depress myocardial function (beta- or calcium
blockers) or promote sodium retention (nonsteroidal anti-
inflammatorydrugs) or the patient's inability to follow pre-
scribed therapy because of economic constraints.
Pathophysiology
The most common pathophysiologic abnormality under-
lying heart failure is ventricular systolic dysfunction, which
is characterized by a decreased ejection fraction. In the
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elderly patient without cardiac enlargement. diastolic dys-
function may predominate. particularly when hypertension,
hypertrophic cardiomyopathy or other causes for left ven-
tricular hypertrophyare present (5,6). Decreased ventricular
compliance and elevation of the pulmonary capillary pres-
sure often produce pulmonary congestion (7). The left ven-
tricular ejection fraction may be normalor slight!y decreased
in these patients with left ventricular diastolic dysfunction.
pulmonary hypertension and heart failure. The prognosis of
elderly patients with congestive heart failure due to diastolic
left ventricular dysfunction without major systolic dysfunc-
tion is significantly better than that of elderly patients with
congestive heart failure and a Jow ejection fraction (8). It
is also important to recognize the occasional elderly patient
with high-output cardiac failure due to hyperthyroidism.
anemia, arteriovenous fistula or Paget's disease, because
these problems are often amenable to specific therapy.
Recognition of Heart Failure
The difficulty in the recognition of heart failure in the
elderly is partly related to manifestations of coexisting res-
piratory, urinary tract and other diseases. The sedentary Iife-
style of older patients, either because of habit or because
of noncardiac disease, may mask or mimic manifestations
of hear! failure. Many of the symptoms of heart failure are
the consequences of the compensatory mechanisms: tachy-
cardia and vasoconstriction due to increased catechol-
arnines. and sodium and water retention resulting in an
expansion of the extracellular fluid volume. The clinical
manifestations of these compensatory adjustments such as
hypertension and edema may be absent or less prominent
with chronic compensated heart failure.
Clinical Features
Dyspnea usually is the most prominent manifesuuion,
commonly presenting as effort dyspnea. and often progres-
sing to orthopnea, paroxysmal nocturnal dyspnea and pul-
monary edema. However, dyspnea may also be a manifes-
tation of myocardial ischemia-induced transient diastolic
dysfunction rather than ventricularsystolic failure. It is often
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difficult clinically to differentiate cardiac from pulmonary
causes of excessive breathlessness before the development
of pulmonary congestion or nocturia. Pulmonary dyspnea
may reflect impaired ventilation secondary to chronic bron-
chitis and emphysema. Also, Cheyne-Stokes respiration may
be erroneously perceived as episodic shortness of breath.
Prominent ventilatory limitation to exercise may be dem-
onstrated at an exercise test monitoring respiratory gas ex-
change; patients with this problem may develop hypoxemia
or attain a level of ventilation that represents a major portion
of their maximal voluntary ventilation at the time they ex-
perience breathlessness.
Easy fatigability, weakness and activity limitation are
common but nonspecific manifestations of a reduced cardiac
output. Peripheral vasoconstriction may produce cold limbs,
and increased circulating catecholamines may result in a
feeling of anxiety. Reduced cerebral perfusion may lead to
confusion, somnolence or other alterations in mental status
or behavior.
Evidence of sodium and water retention includes weight
gain, nocturia and gastrointestinal symptoms-loss of ap-
petite, nausea, early satiety, abdominal discomfort or con-
stipation. These gastrointestinal symptoms due to the insid-
ious onset of right ventricular failure may draw attention
away from the heart. Elevation of the jugular venous pres-
sure points to a cardiac origin. There may also be cardiac
enlargement, gallop sounds, hepatomegaly, edema, pleural
effusion, ascites, pulsus altemans and Cheyne-Stokes res-
piration. However, isolated pedal edema is often noncar-
diac, related to venous insufficiency or local factors. Pul-
monary rales are not a reliable sign of left heart failure
because of the frequency of chronic pulmonary disease in
the elderly.
No electrocardiographic (ECG) abnormality is charac-
teristic ofheart failure. but ECG abnormalities may suggest
an underlying condition such as left ventricular hypertrophy
or myocardial infarction.
Noninvasive Diagnostic Techniques
Noninvasive techniques for evaluating cardiac function
have considerably improved the recognition of heart failure
in the elderly. The chest X-ray film provides an assessment
of the pulmonary vasculature and is particularly valuable in
identifying pulmonary venous hypertension and coexisting
pulmonary disease. Cardiac chamber size and function are
best evaluated by the echocardiogram (9) or radionuclide
angiocardiogram. Both may help distinguish between sys-
tolic and diastolic dysfunction of the left ventricle. Increased
left atrial size with delayed atrial emptying suggests diastolic
dysfunction. Radionuclide techniques can best help assess
the response of left ventricular function to activity. How-
ever, the measurement of left ventricular systolic function
does not correlate well either with symptomatic heart failure
or with exercise capacity (10).
Exercise testing. Even in the absence of heart failure,
the ability of SOme elderly people to perform a satisfactory
exercise test may be limited by physical deconditioning or
by associated peripheral vascular disease, degenerative joint
disease and musculoskeletal and neurologic disorders. How-
ever, in an experienced laboratory a supervised, slowly in-
cremental exercise test, with monitoring of oxygen uptake,
carbon dioxide production, minute ventilation, ECG and
blood pressure can detect the severity of chronic cardiac or
circulatory failure, as well as monitor the progression of
failure over time and its response to therapy (11,12). It can
also differentiate ventilatory from circulatory causes of ex-
ertional dyspnea. The low level exercise test can be per-
formed and tolerated by most elderly patients who can walk
without difficulty.
This procedure can define: a) maximal oxygen uptake
(13), b) anaerobic threshold, and c) the ventilatory response
to exercise. Cardiocirculatory fitness is reflected by the max-
imal oxygen uptake. Maximal oxygen uptake and anaerobic
threshold reflect the degree of cardiac or circulatory im-
pairment and predict the patient's cardiac reserve or cardiac
output response to exercise (14). Abnormalities of venti-
latory response to exercise testing may identify pulmonary
disease as a cause of exertional dyspnea; many patients
thought to have exertional dyspnea secondary to heart dis-
ease may have coexistent and dominant pulmonary disease
with an abnormal ventilatory response to exercise.
Management of Heart Failure
Indications. The goals of treatment in the elderly are
identical to those in younger patients: improvement of car-
diovascular performance, reduction of morbidity, increase
in exercise tolerance (15) and a prolongation of life. Current
indications for treating heart failure include the presence of
symptoms that limit life-style and signs or symptoms that
may herald premature death. In assessing the poor prognosis
of patients with heart failure (16), age itself has not emerged
as an independent prognostic factor. Mortality appears re-
lated to hemodynamic abnormalities, severity of left ven-
tricular dysfunction and underlying disease responsible for
of the heart failure. Improvements in indexes of cardiac
function may favorably influence survival and morbidity.
Recent data in a younger population (17) suggest a prolon-
gation of survival when vasodilator therapy is added to
digitalis and diuretics. Exercise tolerance objectively mea-
sures symptomatic status and one component of quality of
life, but its relation to prognosis is unclear.
Response to drug therapy. There is little evidence that
the elderly have a different qualitative response to drugs or
develop increased side effects with drugs. However, quan-
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titative differences in response are often evident. Age alone
does not enhance sensitivity to drugs or reduce the henefits
of therapy, but may require changes in drug dosage. Age
has not been a factor distinguishing responders from non-
responders in mostcontrolled trials of the treatment of heart
failure in regard to improvement in exercise tolerance and
hemodynamics, reduced symptomatology and morhidity (18) .
The major reason for adverse responses to drugs in the
elderly relates to the presence of associated diseases that
impair renal, gastrointestinal, pulmonary and autonomic
nervous system function. Diminished renal function is usu-
ally present in the elderly even when the serum creatinine
level is normal. These alterations, rather than age itself,
account for the altered drug metabolism, disposition and
responsiveness. Advancedage, however, mandates a careful
assessment for the presence of associated diseases that may
affect treatment choices. Elderly patients do not respond
differently than younger individuals to nitroprusside, ni-
trates. hydralazine or angiotensin-converting enzyme inhib-
itors (19). but frequently require lower dosages. The like-
lihood of digitalis toxicity is notgreater inanelderly population
when proper adjustment in digitalis dosage is made for renal
dysfunction, associated disease and the decreased volume
of distribution. Elderlypatients shouldbe included in studies
of experimental drugs currently being tested for the man-
agement of heart failure.
General management. The management of the elderly
patient with heart failure involves identifying and elimi-
nating precipitating factors. As with younger patients. it
also includes attempts to improve left ventricular function.
to optimize the loading conditions of the heart and to limit
sodium and water retention. Conversion of atrial fibrillation
or atrial flutter to sinus rhythm may augment the cardiac
output. Therefore. the cornerstones of management include
recommendations for appropriate levels of physical activity.
monitoring of daily weight, administration of digitalis to
improve left ventricular function when systolic function is
impaired. diuretic and vasodilator therapy to optimize load-
ing conditions and decreased sodium intake to limit tluid
retention. Arterial dilator drugs may be advantageous in
decreasing left ventricular stress and venodilators reduce
ventricular fill ing pressures. However, treatment of heart
failure due predominantly to diastolic dysfunction with ven-
odilator drugs and diuretics alone may be disadvantageous
because these agents reduce ventricular filling volume and
may thereby reduce cardiac output. Digitalis therapy is in-
dicated in elderly patients with moderate or severe heart
failure, even with sinus rhythm, particularly when cardio-
megaly and low cardiac output are present; improvement in
ejection fraction usually occurs, even with relatively low
serum digoxin concentrations (20). Digitalis has marginal
benefit in elderly patients who have mild congestive heart
failure. a high ventricular ejection fractionand sinus rhythm.
The use of calcium blocking drugs to treat left ventricular
failure remains controversial; hazards include depression of
left ventricular function and bradycardia, and other arterial
dilators are available that produce better results (21).
Side effects of treatment. Excessive immobilization may
predispose to thromboembolism. Excessive diuresis should
be avoided because it may limit cerebral perfusion, cause
confusion and further impair renal function, and it can be
associated with hypokalemia, which may cause arrhythmias
that further worsen heart failure. Digitalis has a narrow
therapeutic margin; bradycardia or AV block, or both, is
commonly accentuated by the concomitant use of beta-
blocking agents, reserpine or calcium blocking drugs. Quin-
idine may increase serum digoxin levels and induce atrial
or ventricular tachyarrhythmias, or both, due to digitalis
excess. Vasodilator drugs often produce postural hypoten-
sion.
Patient compliance. The elderly population, as a whole,
is compliant with drug therapy, possibly related to their
increased need for medical treatment and the availability of
medical care. They du not appear to differ from younger
patients in taking medications as prescribed, following rec-
ommendations and maintaining follow-up, all of which en-
hance the chances for successful treatment. Detailed, pref-
erably written. instructions about medications are needed.
Rehabilitation. Psychologic and rehabilitative support
are important components of therapy. Improvement in eX.-
ercise capacity can reasonably he expected after treatment
of heart failure in the elderly. and exercise training can
further improve exercise tolerance and may improve the
quality of life. The favorable training response relates pri-
marily to peripheral circulatory and skeletal muscle adap-
tations, rather than to a change in myocardial function. A
rational exercise training regimen for elderly patients can
be based on data obtained at exercise testing.
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